Patients with cancer undergoing individually tailored exercise intervention also reported less mental fatigue.

Implementing a simple exercise plan during chemotherapy may ease cognitive impairment and fatigue, promoting better health outcomes for cancer patients.

We already know that some exercise is better than none when it comes to staying healthy. But, there may be even more benefits to fitting just 10 minutes of movement into your daily routine. According ...

While cancer risk is incredibly complex, existing research suggests that being physically active can drop your odds of developing several forms of cancer. For the study, researchers recruited 30 men ...

Exercise has numerous advantages, including improving benefits for individuals with cancer. Observational studies have shown links between cancer outcomes and physical activity, and new research has ...

I tend to think of this weekly fitness blog as being for people who are, well, fit. I take for granted the fact that I’m healthy, active, and able to do things like run and swim without a second ...

Immunotherapy has transformed cancer treatment by harnessing the body's own immune system to fight disease. But many engineered immune cells lose strength quickly after they enter the body, especially ...

You know the virtues of regular physical activity: it can lower your risk of becoming overweight and can keep diseases like heart problems and diabetes at bay. But can it help reduce the risk of ...

Reducing calorie intake helps cancer-fighting immune cells do their jobs more effectively, reports a study by Van Andel Institute scientists and collaborators. The findings lay the groundwork for ...

Reducing calorie intake helps cancer-fighting immune cells do their jobs more effectively, reports a study by Van Andel Institute scientists and collaborators. The findings lay the groundwork for ...

Investigators examined the effects of exercise on cancer-related cognitive impairment (CRCI) and mental fatigue in patients receiving chemotherapy in a multicenter phase III randomized controlled ...